Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

RayVio

Explore full profile

RayVio is an advanced health and hygiene company that delivers clean water and environments

Hayward, United StatesFounded 2012Home Living
Valuation $100–500M Latest valuation · 2016
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for RayVio and the history behind them.

About RayVio

RayVio Corporation operated as a specialized health and hygiene company focused on developing and manufacturing ultraviolet (UV) LED technology. Founded in 2012 by Dr. Robert C. Walker, Yitao Liao, Theodore Moustakas, and Milan Minsky, the company aimed to provide solutions for water and environmental disinfection. The foundational technology stemmed from the doctoral thesis of co-founder Yitao Liao, which focused on enhancing the efficiency and affordability of UV LED technology. RayVio was headquartered in Hayward, California, and is now out of business. The company's business model centered on supplying its patented UV LED components to original equipment manufacturer (OEM) partners. These partners would then integrate RayVio's technology into a new generation of health and hygiene products. RayVio's primary market was the disinfection sector, targeting applications in water purification, air and surface disinfection, healthcare, and consumer products. Over its lifespan, the company raised a total of $35.3 million in funding over three rounds from investors including IPV Capital, Tsing Capital, DCM Ventures, and Capricorn Investment Group. RayVio's core product was a series of powerful and compact UV LEDs. A key product line, the XP Series, was capable of delivering 60mW of UV light, a benchmark performance that enabled sterilization of flowing water and medical instruments without using traditional mercury lamps. Another product line, the XE Series, offered medium-power UV LEDs in a compact 3535 package for high-volume consumer applications like disinfection and phototherapy. These UV LEDs operated in the 280 to 290-nanometer wavelength range, which deactivates the DNA of pathogens like bacteria and viruses. This technology was positioned as a chemical-free and mercury-free solution for on-demand disinfection in products such as self-disinfecting water bottles, humidifiers, and hospital surface cleaners. The company's technology was distributed globally through partners like Digi-Key Electronics. A significant event in the company's history was a patent infringement lawsuit won by Nitride Semiconductor in January 2020, which declared that RayVio had infringed on Nitride's patent. According to PitchBook, the company underwent liquidation in June 2019. Keywords: UV LED, ultraviolet disinfection, water purification, surface disinfection, health and hygiene technology, semiconductor, OEM components, UV-C LED, germicidal irradiation, pathogen deactivation, clean water technology, point-of-use disinfection, mercury-free sterilization, LED manufacturing, environmental hygiene, healthcare disinfection, consumer health products, advanced materials, solid-state lighting, microbial inactivation

Source: Dealroom company data

At a glance

Status
Closed
Founded
2012
Headquarters
Hayward, United States
Employees
2
Open positions
None listed
Dealroom signal
0.0/100
Sector
Home Living, Appliances, Sustainable Development Goals, Wearable, Climate Tech, Hard Tech, DT and LS, science-based
Technology
Artificial Intelligence, Hardware, Deep Tech, Computer Vision, Connected Device
Business model
Manufacturing
Client focus
b2c

Latest news

Press, funding announcements and product moves mentioning RayVio.

See all news

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES CEquity / VC Dec 2017 Bascom Ventures
SERIES CEquity / VC Apr 2016 $26M $104M IPV Capital · DCM · Tsing Capital · Capricorn Investment Group
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

RayVio website traffic

Latest recorded traffic for RayVio is 230 monthly website visits, down 91.5% over the last three months. RayVio's team declined 66.7% over the past year.

Latest monthly visits230 3-month web change-91.5% 1-year team growth-66.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • DCM
  • Capricorn Investment Group
  • Tolero Ventures
  • Applied Ventures
  • New Ground Ventures
  • Augment Ventures

Series B and later3 investors entered at this stage

  • IPV Capital
  • Tsing Capital
  • Bascom Ventures

Other known investors1 additional known investor

Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Hayward HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about RayVio on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See RayVio’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.